Moving towards Universal Coverage of Direct-Acting Antiviral Therapies for Hepatitis C Infection in Canada: An Environmental Scan of Canadian Provinces and International Jurisdictions.

CONCLUSION: DAAs appear to be generally accessible through public drug plans in Canada compared to other countries. PMID: 30407908 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30407908?dopt=Abstract

Source: J Pharm Pharm Sci - November 10, 2018 Category: Drugs & Pharmacology Authors: Myers S, Khosa G, Kuo IF, Janzen D, Alessi-Severini S Tags: J Pharm Pharm Sci Source Type: research